Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.
van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nubé MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM; CONTRAST Investigators.
van der Weerd NC, et al. Among authors: blankestijn pj.
PLoS One. 2012;7(7):e39783. doi: 10.1371/journal.pone.0039783. Epub 2012 Jul 13.
PLoS One. 2012.
PMID: 22808058
Free PMC article.
Clinical Trial.